Look at where VNDA's market cap is currently and where it has been as your guide. Fanapt their 'me too schizo drug' averages them about $15 million a quarter in sales. Titan's approval milestone payment is $15 million alone and sales are projected to be in the $200 to 300 million range annually(those are more conservative estimates).
VNDA just got approval to for maintenance indication in schizophrenia today too and is up 8% after-hours. They have just over 2x the number of shares of Titan outstanding. I have owned VNDA in the past years ago too.